Study of antibodies in anorexia with liver damage
Treatments studied
Part of Digestive system clinical trials.
This study looks for certain antibodies in the blood of people with anorexia nervosa who also have liver problems. It aims to understand if these antibodies contribute to liver damage, which may help find new ways to treat or prevent this complication.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 6 and 65 years old
- You have been diagnosed with anorexia nervosa
- You have undernutrition according to French health guidelines
- You can understand French and agree to participate
- You are covered by French social security
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies people with liver disease linked to alcohol use or metabolic syndrome (a cluster of conditions like weight gain and insulin resistance). It uses recent standard-of-care liver biopsy results to better understand these chronic liver problems and how they relate to cancer risk.
This trial checks if the absence of certain antibodies in autoimmune hepatitis (AIH) is linked to more severe disease. It may help doctors better understand and treat AIH.
This study looks at how your body uses protein in your muscles when you have cirrhosis (a scarred liver). It uses a special “tracer” method (a substance that can be tracked) and may help researchers better understand muscle loss in people with milder cirrhosis.
This study looks at how alcoholic liver disease may change a natural body clean-up process in muscle. It compares people with alcoholic liver disease to people without it to better understand the biology and identify possible targets for treatment.
This study collects information and blood samples from people with autoimmune hepatitis and other liver conditions to better understand these diseases. Taking part may help with research, though it is not a treatment trial.
This study collects health information from people with non-alcoholic fatty liver disease (NAFLD), a condition where fat builds up in the liver. It aims to learn more about the disease to improve future care.
Hear when a new Hepatic Cytolysis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.